AVISE® MTX provides accurate measurement of active methotrexate (MTXPGs) to help physicians appropriately assess their patients' MTX dose & exposure to optimize therapy.

By utilizing AVISE® MTX, physicians can better determine if a patients’ MTXPG levels are sub-therapeutic, intermediate or therapeutic to make data-based decisions on MTX dosing, delivery method and the addition or switch of DMARDs.

To learn more about the clinical utility of AVISE® MTX from your peers or read current scientific publications, please visit our Education & Resources library.